Global Rivaroxaban Market Growth 2023-2028

Report ID: 1165527 | Published Date: Jan 2025 | No. of Page: 71 | Base Year: 2024 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Rivaroxaban Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for Rivaroxaban by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for Rivaroxaban by Country/Region, 2017, 2022 & 2028
    2.2 Rivaroxaban Segment by Type
        2.2.1 2.5 mg
        2.2.2 10 mg
        2.2.3 15 mg
        2.2.4 20 mg
    2.3 Rivaroxaban Sales by Type
        2.3.1 Global Rivaroxaban Sales Market Share by Type (2017-2022)
        2.3.2 Global Rivaroxaban Revenue and Market Share by Type (2017-2022)
        2.3.3 Global Rivaroxaban Sale Price by Type (2017-2022)
    2.4 Rivaroxaban Segment by Application
        2.4.1 Acute Coronary Syndrome (ACS)
        2.4.2 Venous Thromboembolism (VTE)
    2.5 Rivaroxaban Sales by Application
        2.5.1 Global Rivaroxaban Sale Market Share by Application (2017-2022)
        2.5.2 Global Rivaroxaban Revenue and Market Share by Application (2017-2022)
        2.5.3 Global Rivaroxaban Sale Price by Application (2017-2022)
3 Global Rivaroxaban by Company
    3.1 Global Rivaroxaban Breakdown Data by Company
        3.1.1 Global Rivaroxaban Annual Sales by Company (2020-2022)
        3.1.2 Global Rivaroxaban Sales Market Share by Company (2020-2022)
    3.2 Global Rivaroxaban Annual Revenue by Company (2020-2022)
        3.2.1 Global Rivaroxaban Revenue by Company (2020-2022)
        3.2.2 Global Rivaroxaban Revenue Market Share by Company (2020-2022)
    3.3 Global Rivaroxaban Sale Price by Company
    3.4 Key Manufacturers Rivaroxaban Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Rivaroxaban Product Location Distribution
        3.4.2 Players Rivaroxaban Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Rivaroxaban by Geographic Region
    4.1 World Historic Rivaroxaban Market Size by Geographic Region (2017-2022)
        4.1.1 Global Rivaroxaban Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global Rivaroxaban Annual Revenue by Geographic Region
    4.2 World Historic Rivaroxaban Market Size by Country/Region (2017-2022)
        4.2.1 Global Rivaroxaban Annual Sales by Country/Region (2017-2022)
        4.2.2 Global Rivaroxaban Annual Revenue by Country/Region
    4.3 Americas Rivaroxaban Sales Growth
    4.4 APAC Rivaroxaban Sales Growth
    4.5 Europe Rivaroxaban Sales Growth
    4.6 Middle East & Africa Rivaroxaban Sales Growth
5 Americas
    5.1 Americas Rivaroxaban Sales by Country
        5.1.1 Americas Rivaroxaban Sales by Country (2017-2022)
        5.1.2 Americas Rivaroxaban Revenue by Country (2017-2022)
    5.2 Americas Rivaroxaban Sales by Type
    5.3 Americas Rivaroxaban Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Rivaroxaban Sales by Region
        6.1.1 APAC Rivaroxaban Sales by Region (2017-2022)
        6.1.2 APAC Rivaroxaban Revenue by Region (2017-2022)
    6.2 APAC Rivaroxaban Sales by Type
    6.3 APAC Rivaroxaban Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe Rivaroxaban by Country
        7.1.1 Europe Rivaroxaban Sales by Country (2017-2022)
        7.1.2 Europe Rivaroxaban Revenue by Country (2017-2022)
    7.2 Europe Rivaroxaban Sales by Type
    7.3 Europe Rivaroxaban Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Rivaroxaban by Country
        8.1.1 Middle East & Africa Rivaroxaban Sales by Country (2017-2022)
        8.1.2 Middle East & Africa Rivaroxaban Revenue by Country (2017-2022)
    8.2 Middle East & Africa Rivaroxaban Sales by Type
    8.3 Middle East & Africa Rivaroxaban Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Rivaroxaban
    10.3 Manufacturing Process Analysis of Rivaroxaban
    10.4 Industry Chain Structure of Rivaroxaban
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Rivaroxaban Distributors
    11.3 Rivaroxaban Customer
12 World Forecast Review for Rivaroxaban by Geographic Region
    12.1 Global Rivaroxaban Market Size Forecast by Region
        12.1.1 Global Rivaroxaban Forecast by Region (2023-2028)
        12.1.2 Global Rivaroxaban Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Rivaroxaban Forecast by Type
    12.7 Global Rivaroxaban Forecast by Application
13 Key Players Analysis
    13.1 Bayer
        13.1.1 Bayer Company Information
        13.1.2 Bayer Rivaroxaban Product Offered
        13.1.3 Bayer Rivaroxaban Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Bayer Main Business Overview
        13.1.5 Bayer Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. Rivaroxaban Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. Rivaroxaban Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of 2.5 mg
    Table 4. Major Players of 10 mg
    Table 5. Major Players of 15 mg
    Table 6. Major Players of 20 mg
    Table 7. Global Rivaroxaban Sales by Type (2017-2022) & (M Units)
    Table 8. Global Rivaroxaban Sales Market Share by Type (2017-2022)
    Table 9. Global Rivaroxaban Revenue by Type (2017-2022) & ($ million)
    Table 10. Global Rivaroxaban Revenue Market Share by Type (2017-2022)
    Table 11. Global Rivaroxaban Sale Price by Type (2017-2022) & (US$/Unit)
    Table 12. Global Rivaroxaban Sales by Application (2017-2022) & (M Units)
    Table 13. Global Rivaroxaban Sales Market Share by Application (2017-2022)
    Table 14. Global Rivaroxaban Revenue by Application (2017-2022)
    Table 15. Global Rivaroxaban Revenue Market Share by Application (2017-2022)
    Table 16. Global Rivaroxaban Sale Price by Application (2017-2022) & (US$/Unit)
    Table 17. Global Rivaroxaban Sales by Company (2020-2022) & (M Units)
    Table 18. Global Rivaroxaban Sales Market Share by Company (2020-2022)
    Table 19. Global Rivaroxaban Revenue by Company (2020-2022) ($ Millions)
    Table 20. Global Rivaroxaban Revenue Market Share by Company (2020-2022)
    Table 21. Global Rivaroxaban Sale Price by Company (2020-2022) & (US$/Unit)
    Table 22. Key Manufacturers Rivaroxaban Producing Area Distribution and Sales Area
    Table 23. Players Rivaroxaban Products Offered
    Table 24. Rivaroxaban Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 25. New Products and Potential Entrants
    Table 26. Mergers & Acquisitions, Expansion
    Table 27. Global Rivaroxaban Sales by Geographic Region (2017-2022) & (M Units)
    Table 28. Global Rivaroxaban Sales Market Share Geographic Region (2017-2022)
    Table 29. Global Rivaroxaban Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 30. Global Rivaroxaban Revenue Market Share by Geographic Region (2017-2022)
    Table 31. Global Rivaroxaban Sales by Country/Region (2017-2022) & (M Units)
    Table 32. Global Rivaroxaban Sales Market Share by Country/Region (2017-2022)
    Table 33. Global Rivaroxaban Revenue by Country/Region (2017-2022) & ($ millions)
    Table 34. Global Rivaroxaban Revenue Market Share by Country/Region (2017-2022)
    Table 35. Americas Rivaroxaban Sales by Country (2017-2022) & (M Units)
    Table 36. Americas Rivaroxaban Sales Market Share by Country (2017-2022)
    Table 37. Americas Rivaroxaban Revenue by Country (2017-2022) & ($ Millions)
    Table 38. Americas Rivaroxaban Revenue Market Share by Country (2017-2022)
    Table 39. Americas Rivaroxaban Sales by Type (2017-2022) & (M Units)
    Table 40. Americas Rivaroxaban Sales Market Share by Type (2017-2022)
    Table 41. Americas Rivaroxaban Sales by Application (2017-2022) & (M Units)
    Table 42. Americas Rivaroxaban Sales Market Share by Application (2017-2022)
    Table 43. APAC Rivaroxaban Sales by Region (2017-2022) & (M Units)
    Table 44. APAC Rivaroxaban Sales Market Share by Region (2017-2022)
    Table 45. APAC Rivaroxaban Revenue by Region (2017-2022) & ($ Millions)
    Table 46. APAC Rivaroxaban Revenue Market Share by Region (2017-2022)
    Table 47. APAC Rivaroxaban Sales by Type (2017-2022) & (M Units)
    Table 48. APAC Rivaroxaban Sales Market Share by Type (2017-2022)
    Table 49. APAC Rivaroxaban Sales by Application (2017-2022) & (M Units)
    Table 50. APAC Rivaroxaban Sales Market Share by Application (2017-2022)
    Table 51. Europe Rivaroxaban Sales by Country (2017-2022) & (M Units)
    Table 52. Europe Rivaroxaban Sales Market Share by Country (2017-2022)
    Table 53. Europe Rivaroxaban Revenue by Country (2017-2022) & ($ Millions)
    Table 54. Europe Rivaroxaban Revenue Market Share by Country (2017-2022)
    Table 55. Europe Rivaroxaban Sales by Type (2017-2022) & (M Units)
    Table 56. Europe Rivaroxaban Sales Market Share by Type (2017-2022)
    Table 57. Europe Rivaroxaban Sales by Application (2017-2022) & (M Units)
    Table 58. Europe Rivaroxaban Sales Market Share by Application (2017-2022)
    Table 59. Middle East & Africa Rivaroxaban Sales by Country (2017-2022) & (M Units)
    Table 60. Middle East & Africa Rivaroxaban Sales Market Share by Country (2017-2022)
    Table 61. Middle East & Africa Rivaroxaban Revenue by Country (2017-2022) & ($ Millions)
    Table 62. Middle East & Africa Rivaroxaban Revenue Market Share by Country (2017-2022)
    Table 63. Middle East & Africa Rivaroxaban Sales by Type (2017-2022) & (M Units)
    Table 64. Middle East & Africa Rivaroxaban Sales Market Share by Type (2017-2022)
    Table 65. Middle East & Africa Rivaroxaban Sales by Application (2017-2022) & (M Units)
    Table 66. Middle East & Africa Rivaroxaban Sales Market Share by Application (2017-2022)
    Table 67. Key Market Drivers & Growth Opportunities of Rivaroxaban
    Table 68. Key Market Challenges & Risks of Rivaroxaban
    Table 69. Key Industry Trends of Rivaroxaban
    Table 70. Rivaroxaban Raw Material
    Table 71. Key Suppliers of Raw Materials
    Table 72. Rivaroxaban Distributors List
    Table 73. Rivaroxaban Customer List
    Table 74. Global Rivaroxaban Sales Forecast by Region (2023-2028) & (M Units)
    Table 75. Global Rivaroxaban Sales Market Forecast by Region
    Table 76. Global Rivaroxaban Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 77. Global Rivaroxaban Revenue Market Share Forecast by Region (2023-2028)
    Table 78. Americas Rivaroxaban Sales Forecast by Country (2023-2028) & (M Units)
    Table 79. Americas Rivaroxaban Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 80. APAC Rivaroxaban Sales Forecast by Region (2023-2028) & (M Units)
    Table 81. APAC Rivaroxaban Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 82. Europe Rivaroxaban Sales Forecast by Country (2023-2028) & (M Units)
    Table 83. Europe Rivaroxaban Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 84. Middle East & Africa Rivaroxaban Sales Forecast by Country (2023-2028) & (M Units)
    Table 85. Middle East & Africa Rivaroxaban Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 86. Global Rivaroxaban Sales Forecast by Type (2023-2028) & (M Units)
    Table 87. Global Rivaroxaban Sales Market Share Forecast by Type (2023-2028)
    Table 88. Global Rivaroxaban Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 89. Global Rivaroxaban Revenue Market Share Forecast by Type (2023-2028)
    Table 90. Global Rivaroxaban Sales Forecast by Application (2023-2028) & (M Units)
    Table 91. Global Rivaroxaban Sales Market Share Forecast by Application (2023-2028)
    Table 92. Global Rivaroxaban Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 93. Global Rivaroxaban Revenue Market Share Forecast by Application (2023-2028)
    Table 94. Bayer Basic Information, Rivaroxaban Manufacturing Base, Sales Area and Its Competitors
    Table 95. Bayer Rivaroxaban Product Offered
    Table 96. Bayer Rivaroxaban Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 97. Bayer Main Business
    Table 98. Bayer Latest Developments
    Table 99. J&J Basic Information, Rivaroxaban Manufacturing Base, Sales Area and Its Competitors
    Table 100. J&J Rivaroxaban Product Offered
    Table 101. J&J Rivaroxaban Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 102. J&J Main Business
    Table 103. J&J Latest Developments
List of Figures
    Figure 1. Picture of Rivaroxaban
    Figure 2. Rivaroxaban Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Rivaroxaban Sales Growth Rate 2017-2028 (M Units)
    Figure 7. Global Rivaroxaban Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. Rivaroxaban Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of 2.5 mg
    Figure 10. Product Picture of 10 mg
    Figure 11. Product Picture of 15 mg
    Figure 12. Product Picture of 20 mg
    Figure 13. Global Rivaroxaban Sales Market Share by Type in 2021
    Figure 14. Global Rivaroxaban Revenue Market Share by Type (2017-2022)
    Figure 15. Rivaroxaban Consumed in Acute Coronary Syndrome (ACS)
    Figure 16. Global Rivaroxaban Market: Acute Coronary Syndrome (ACS) (2017-2022) & (M Units)
    Figure 17. Rivaroxaban Consumed in Venous Thromboembolism (VTE)
    Figure 18. Global Rivaroxaban Market: Venous Thromboembolism (VTE) (2017-2022) & (M Units)
    Figure 19. Global Rivaroxaban Sales Market Share by Application (2017-2022)
    Figure 20. Global Rivaroxaban Revenue Market Share by Application in 2021
    Figure 21. Rivaroxaban Revenue Market by Company in 2021 ($ Million)
    Figure 22. Global Rivaroxaban Revenue Market Share by Company in 2021
    Figure 23. Global Rivaroxaban Sales Market Share by Geographic Region (2017-2022)
    Figure 24. Global Rivaroxaban Revenue Market Share by Geographic Region in 2021
    Figure 25. Global Rivaroxaban Sales Market Share by Region (2017-2022)
    Figure 26. Global Rivaroxaban Revenue Market Share by Country/Region in 2021
    Figure 27. Americas Rivaroxaban Sales 2017-2022 (M Units)
    Figure 28. Americas Rivaroxaban Revenue 2017-2022 ($ Millions)
    Figure 29. APAC Rivaroxaban Sales 2017-2022 (M Units)
    Figure 30. APAC Rivaroxaban Revenue 2017-2022 ($ Millions)
    Figure 31. Europe Rivaroxaban Sales 2017-2022 (M Units)
    Figure 32. Europe Rivaroxaban Revenue 2017-2022 ($ Millions)
    Figure 33. Middle East & Africa Rivaroxaban Sales 2017-2022 (M Units)
    Figure 34. Middle East & Africa Rivaroxaban Revenue 2017-2022 ($ Millions)
    Figure 35. Americas Rivaroxaban Sales Market Share by Country in 2021
    Figure 36. Americas Rivaroxaban Revenue Market Share by Country in 2021
    Figure 37. United States Rivaroxaban Revenue Growth 2017-2022 ($ Millions)
    Figure 38. Canada Rivaroxaban Revenue Growth 2017-2022 ($ Millions)
    Figure 39. Mexico Rivaroxaban Revenue Growth 2017-2022 ($ Millions)
    Figure 40. Brazil Rivaroxaban Revenue Growth 2017-2022 ($ Millions)
    Figure 41. APAC Rivaroxaban Sales Market Share by Region in 2021
    Figure 42. APAC Rivaroxaban Revenue Market Share by Regions in 2021
    Figure 43. China Rivaroxaban Revenue Growth 2017-2022 ($ Millions)
    Figure 44. Japan Rivaroxaban Revenue Growth 2017-2022 ($ Millions)
    Figure 45. South Korea Rivaroxaban Revenue Growth 2017-2022 ($ Millions)
    Figure 46. Southeast Asia Rivaroxaban Revenue Growth 2017-2022 ($ Millions)
    Figure 47. India Rivaroxaban Revenue Growth 2017-2022 ($ Millions)
    Figure 48. Australia Rivaroxaban Revenue Growth 2017-2022 ($ Millions)
    Figure 49. Europe Rivaroxaban Sales Market Share by Country in 2021
    Figure 50. Europe Rivaroxaban Revenue Market Share by Country in 2021
    Figure 51. Germany Rivaroxaban Revenue Growth 2017-2022 ($ Millions)
    Figure 52. France Rivaroxaban Revenue Growth 2017-2022 ($ Millions)
    Figure 53. UK Rivaroxaban Revenue Growth 2017-2022 ($ Millions)
    Figure 54. Italy Rivaroxaban Revenue Growth 2017-2022 ($ Millions)
    Figure 55. Russia Rivaroxaban Revenue Growth 2017-2022 ($ Millions)
    Figure 56. Middle East & Africa Rivaroxaban Sales Market Share by Country in 2021
    Figure 57. Middle East & Africa Rivaroxaban Revenue Market Share by Country in 2021
    Figure 58. Egypt Rivaroxaban Revenue Growth 2017-2022 ($ Millions)
    Figure 59. South Africa Rivaroxaban Revenue Growth 2017-2022 ($ Millions)
    Figure 60. Israel Rivaroxaban Revenue Growth 2017-2022 ($ Millions)
    Figure 61. Turkey Rivaroxaban Revenue Growth 2017-2022 ($ Millions)
    Figure 62. GCC Country Rivaroxaban Revenue Growth 2017-2022 ($ Millions)
    Figure 63. Manufacturing Cost Structure Analysis of Rivaroxaban in 2021
    Figure 64. Manufacturing Process Analysis of Rivaroxaban
    Figure 65. Industry Chain Structure of Rivaroxaban
    Figure 66. Channels of Distribution
    Figure 67. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Rivaroxaban Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Rivaroxaban Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Rivaroxaban Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports